Pharmacokinetics of nicardipine enantiomers in healthy young volunteers

European Journal of Clinical Pharmacology

Volumn 52, Issue 4, 1997, Pages 289-292

  Inotsume, N ^a,b   Iwaoka, T ^c   Honda, M ^b   Nakano, M ^b   Okamoto, Y ^d   Naomi, S ^c   Tomita, K ^c   Teramura, T ^e   Higuchi, S ^e  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY HOSPITAL   (Japan)

^c KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^d NAGOYA UNIVERSITY   (Japan)

^e ASTELLAS PHARMA INC   (Japan)

Author keywords

Enantiomers; Healthy volunteers; Nicardipine; Pharmacokinetics

Indexed keywords

NICARDIPINE;

ADULT; ARTICLE; BIOAVAILABILITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BLOOD LEVEL; ENANTIOMER; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PRIORITY JOURNAL; RACEMIC MIXTURE; SUSTAINED RELEASE PREPARATION; VOLUNTEER;

ADMINISTRATION, ORAL; ADULT; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DELAYED-ACTION PREPARATIONS; HUMANS; MALE; NICARDIPINE; STEREOISOMERISM;

EID: 0030788688     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050292     Document Type: Article

References (19)

1. Sorkin EM, Clissord SP (1987) Nicardipine. Drugs 33: 296-345
2. 2+ antagonist. Jpn J Pharmacol 32: 665-670
3. Tokuma Y, Fujiwara T, Noguchi H (1987) Plasma levels of (+)- and (-)-nilvadipine after oral dosing with racemic (±)-nilvadipine in man. Res Commun Clin Pathol Pharmacol 57: 229-237
4. Tokuma Y, Fujiwara T, Noguchi H (1987) Determination of (+)- and (-)-nilvadipine in human plasma using chiral stationary-phase liquid chromatography and gas chromatography-mass spectrometry, and preliminary pharmacokinetic study in humans. J Pharm Sci 76: 310-313
5. Tokuma Y, Noguchi H (1995) Stereoselective pharmacokinetics of dihydropyridine calcium antagonists. J Chromatogr 694: 181-193
6. Soons PA, Mulders TM, Uchida E, Schoemaker HC, Cohen AF, Breimer DD (1993) Stereoselective pharmacokinetics of oral felodipine and nitrendipine in healthy subjects: correlation with nifedipine pharmacokinetics. Eur J Clin Pharmacol 44: 163-169
7. Soons PA, Cohen AF, Breimer DD (1993) Comparative effects of felodipine, nitrendipine and nifedipine in healthy subjects: concentration-effect relationships of racemic drugs and enantiomers. Eur J Clin Pharmacol 44: 113-120
8. Soons PA, Ankermann T, Breimer DD, Kirch W (1992) Stereoselective pharmacokinetics of oral nitrendipine in elderly hypertensive patients with normal and impaired renal function. Eur J Clin Pharmacol 42: 423-427
9. Soons PA, Breimer DD (1991) Stereoselective pharmacokinetics of oral and intravenous nitrendipine in healthy male subjects. Br J Clin Pharmacol 32: 11-16
10. Chaapeau V, Moulin A, Caude M, Dufour A (1994) High-performance liquid chromatographic determination of oxodipine enantiomers, a new 1,4-dihydropyridine, applied to stereoselectivity studies in man and dog. J Chromatogr 660: 341-346
11. Yamaguchi M, Yamashita K, Aoki I, Tabata T, Hirai S, Yashiki T (1992) Determination of manidipine enantiomer in human serum using chiral chromatography and column-switching chromatography. J Chromatogr 575: 123-129
12. Soons PA, Roosemalen MC, Breimer DD (1990) Enantioselective determination of felodipine and other chiral dihydropyridine calcium entry blockers in human plasma. J Chromatogr 528: 343-356
13. Iwaoka T, Inotsume N, Inoue J, Naomi S, Okamoto Y, Higuchi S, Nakano M, Umeda T (1995) Determination of (+)-and (-)-nicardipine concentrations in human serum and their correlation with the antihypertensive effect after oral administration of racemic nicardipine. Eur J Clin Pharmacol 48: 345-349
14. Drayer DE (1986) Pharmacodynamic and pharmacokinetic differences between drug enantiomers in humans: an overview. Clin Pharmacol Ther 40: 125-133
15. Graham DJM, Dow RJ, Freedman D, Mroszczak EJ, Ling T (1984) Pharmacokinetics of nicardipine following oral and intravenous administration in man. Postgrad Med J 60: 7-10
16. Higuchi S, Shiobara Y (1980) Comparative pharmacokinetics of nicardipine hydrochloride, a new vasodilator, in various species. Xenobiotica 10: 447-454
17. Graham DJM, Dow RJ, Hall DJ, Alexander F, Mroszczak EJ, Freedman D (1985) The metabolism and pharmacokinetics of nicardipine hydrochloride in man. Br J Clin Pharmacol 20: 23S-28S
18. Dow RJ, Graham DJM (1986) A review of human metabolism and pharmacokinetics of nicardipine hydrochloride. Br J Clin Pharmacol 22: 195S-202S
19. Jamali F, Berry BW, Tehrani MR, Russel AS (1988) Stereoselective pharmacokinetics of flurbiprofen in humans and rats. J Pharm Sci 77: 666-669